Paper · 39202075
Advancing the Diagnosis of Diabetic Neuropathies: Electrodiagnostic and Skin Autofluorescence Methods.
Trofin D and 4 others. J Pers Med, 2024. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Advancing the Diagnosis of Diabetic Neuropathies: Electrodiagnostic and Skin Autofluorescence Methods. Papers, record 39202075. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39202075
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Advancing the Diagnosis of Diabetic Neuropathies: Electrodiagnostic and Skin Autofluorescence Methods.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19,077,671 | Ulnar neuropathy at the elbow in diabetes. | Am J Phys Med Rehabil | 2009 | https://conductscience.org/library/papers/19077671 | PubMed |
| 2 | 35,837,045 | Conservative therapy in ulnar neuropathy at the elbow (Review). | Exp Ther Med | 2022 | https://conductscience.org/library/papers/35837045 | PubMed |
| 3 | 21,195,360 | Earlier development of diabetic neuropathy in men than in women with type 2 diabetes mellitus. | Gend Med | 2010 | https://conductscience.org/library/papers/21195360 | PubMed |
| 4 | 33,671,060 | Effectiveness of Conservative Treatment According to Severity and Systemic Disease in Carpal Tunnel Syndrome: A Systematic Review. | Int J Environ Res Public Health | 2021 | https://conductscience.org/library/papers/33671060 | PubMed |
| 5 | 11,270,668 | Advanced glycation end-products: a review. | Diabetologia | 2001 | https://conductscience.org/library/papers/11270668 | PubMed |
| 6 | 29,596,017 | Mechanisms for the increased fatigability of the lower limb in people with type 2 diabetes. | J Appl Physiol (1985) | 2018 | https://conductscience.org/library/papers/29596017 | PubMed |
| 7 | 33,859,898 | Association Between Diabetes Mellitus and Carpal Tunnel Syndrome: Results From the United States National Ambulatory Medical Care Survey. | Cureus | 2021 | https://conductscience.org/library/papers/33859898 | PubMed |
| 8 | 33,622,304 | Skin AGEs and diabetic neuropathy. | BMC Endocr Disord | 2021 | https://conductscience.org/library/papers/33622304 | PubMed |
| 9 | 31,639,835 | A Clinician's Approach to Peripheral Neuropathy. | Semin Neurol | 2019 | https://conductscience.org/library/papers/31639835 | PubMed |
| 10 | 28,748,675 | Does Diabetes Mellitus Influence Carpal Tunnel Syndrome? | J Clin Neurol | 2017 | https://conductscience.org/library/papers/28748675 | PubMed |
1 to 10 of 66
See all 66 referencesCited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,194,936 | Lipid Signatures Associated with Diabetic Peripheral Neuropathy in Obesity and Type 2 Diabetes-A Systematic Review. | J Clin Med | 2026 | https://conductscience.org/library/papers/42194936 | PubMed |
| 41,901,667 | Predictors of Peripheral Neuropathy in Metabolic Disease: A Multivariable Analysis Incorporating the Toronto Clinical Scoring System and Sudomotor Assessment. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/41901667 | PubMed |
| 41,595,554 | The Assessment of the Autonomic Polyneuropathy Through Sudoscan and Vitamin B12 in Patients with Type 2 Diabetes Mellitus and High Cardiovascular Risk or Established Cardiovascular Disease. | Biomedicines | 2025 | https://conductscience.org/library/papers/41595554 | PubMed |
| 40,725,181 | Could Skin Autofluorescence Be a Useful Biomarker in Systemic Lupus Erythematosus? A Systematic Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40725181 | PubMed |
| 39,595,083 | Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes. | Biomedicines | 2024 | https://conductscience.org/library/papers/39595083 | PubMed |
| 39,595,016 | The Impact of Virtual Reality as a Rehabilitation Method Using TRAVEE System on Functional Outcomes and Disability in Stroke Patients: A Pilot Study. | Biomedicines | 2024 | https://conductscience.org/library/papers/39595016 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39202075
GET https://conductscience.org/api/papers/v1/39202075/references?page=2